These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11951863

  • 1. Valsartan in chronic heart failure.
    Campbell DJ.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11951863
    [No Abstract] [Full Text] [Related]

  • 2. Valsartan in chronic heart failure.
    Forfar JC, Munir S.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11951862
    [No Abstract] [Full Text] [Related]

  • 3. Valsartan in chronic heart failure.
    Haddy FJ.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11948282
    [No Abstract] [Full Text] [Related]

  • 4. Valsartan in chronic heart failure.
    Cayley WE.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11951861
    [No Abstract] [Full Text] [Related]

  • 5. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators.
    N Engl J Med; 2001 Dec 06; 345(23):1667-75. PubMed ID: 11759645
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Tepper D.
    Congest Heart Fail; 2002 Dec 06; 8(1):57-8. PubMed ID: 11821630
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Valsartan on hospitalization: results from Val-HeFT.
    Carson P, Tognoni G, Cohn JN.
    J Card Fail; 2003 Jun 06; 9(3):164-71. PubMed ID: 12815565
    [Abstract] [Full Text] [Related]

  • 8. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M.
    Heart Fail Monit; 2002 Jun 06; 2(3):85-7. PubMed ID: 12634889
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 06; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T, Takeshita A.
    Nihon Rinsho; 2003 May 06; 61(5):801-6. PubMed ID: 12755006
    [Abstract] [Full Text] [Related]

  • 11. [Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
    MMW Fortschr Med; 2002 Oct 03; 144(40):49. PubMed ID: 12440300
    [No Abstract] [Full Text] [Related]

  • 12. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD, Friedman JY, Velazquez EJ, Gnanasakthy A, Califf RM, Schulman KA.
    Am Heart J; 2004 Jul 03; 148(1):122-8. PubMed ID: 15215801
    [Abstract] [Full Text] [Related]

  • 13. Anti-angiotensin therapy: new perspectives.
    Ramasubbu K, Mann DL, Deswal A.
    Cardiol Clin; 2007 Nov 03; 25(4):573-80; vi-vii. PubMed ID: 18063161
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z.
    Clin Sci (Lond); 2003 Apr 03; 104(4):341-7. PubMed ID: 12653675
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
    McMurray JJ.
    J Renin Angiotensin Aldosterone Syst; 2001 Jun 03; 2(2):89-92. PubMed ID: 11881104
    [No Abstract] [Full Text] [Related]

  • 16. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW, Berent R, Eber B.
    Circulation; 2001 Oct 09; 104(15):E82. PubMed ID: 11591633
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacological treatment of heart failure].
    Kohno M.
    Nihon Rinsho; 2003 Apr 09; 61 Suppl 4():660-6. PubMed ID: 12735047
    [No Abstract] [Full Text] [Related]

  • 19. [Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
    MMW Fortschr Med; 2003 Oct 23; 145(43):51. PubMed ID: 14664222
    [No Abstract] [Full Text] [Related]

  • 20. [Info-congress. COPERNICUS and Val-HEFT studies].
    Kulbertus H.
    Rev Med Liege; 2000 Nov 23; 55(11):1018-20. PubMed ID: 11195705
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.